MUB Medical Receives Development Loan and Joins Proventia Preincubation Program
MUB Medical is thrilled to announce two major milestones that will propel us forward in our mission to transform the wound closure industry. We have been offered a development loan by Klosterøya Fondet, a testament to our potential for growth and innovation. Additionally, we are excited to share that we have joined the renowned Proventia preincubation program, further strengthening our position in the entrepreneurial ecosystem.
Founder Ubbat Ocak expresses his enthusiasm, stating, “The development loan from Klosterøya Fondet is a significant milestone for MUB Medical. It will provide us with the financial resources needed to accelerate the development of our revolutionary wound closure solutions. We are grateful for the support and trust shown by Klosterøya Fondet in our vision and look forward to delivering innovative products that will make a positive impact.”
CEO Yasar Shaikh adds, “Joining the Proventia preincubation program marks a crucial step in our growth journey. Incubation has proven to be an effective method for nurturing and realizing new business ideas, and we are excited to collaborate with Proventia’s experienced team. Their support in terms of services, infrastructure, networks, and investor connections will be instrumental in shaping our path to success.”
Proventia, established in 2013, is renowned for its dedication to helping entrepreneurs and visionaries commercialize unique business ideas with regional potential. Their focus on supporting and guiding founders aligns perfectly with MUB Medical’s goals. Through this program, we will have access to valuable resources, expertise, and networks that will enable us to refine our business model and maximize our potential for success.
“Proventia’s commitment to developing sound business ideas into profitable ventures resonates with our vision at MUB Medical,” states Yasar Shaikh. “We appreciate their dedication to our success and their role in fostering sustainable growth in the region. Together, we will navigate the entrepreneurial journey, with a shared goal of realizing dreams and creating innovative solutions.”
As we embark on this exciting chapter, we extend our gratitude to Klosterøya Fondet and Proventia for their belief in our vision and their support in our journey to revolutionize the wound closure industry. These partnerships will strengthen our ability to invest in research, development, and analyzing the patent landscape, further solidifying our position as a key player in the healthcare sector.
Stay connected with MUB Medical on our LinkedIn page for updates on our progress, new developments, and exciting milestones. We are committed to advancing wound closure solutions and driving positive change in the industry.